Cell Signalling and Targeted therapy
Our group studies the regulation of cellular signalling and how dysregulation of intracellular signaling pathways may contribute to development of diseases such as cancer. We are particularly interested in understanding how specific protein kinases and protein phosphatases contributes to these processes. Our ultimate goal is to use this knowledge to identify novel strategies for pharmacological treatment of cancer.
Our research projects includes studies of
- Role of DUSP2 in cancer cell signaling in hematological malignancies
- Stress activated signaling pathways in cancer development
- Targeting tissue acidosis in solid tumours
We are also involved in several collaborative projects within the Faculty of Health Sciences (Link microRNA), the University of Tromsø and the Norwegian Cancer Genomics Consortium (link).
The research in our group is made possible with grants from the Norwegian Cancer society, Norwegian research Council, Helse Nord, and the Blix foundation.
Faculty of Health sciences
University of Tromsø